X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.65
Delayed Data
As of 10:35am ET
 -0.03 / -1.79%
Today’s Change
1.61
Today|||52-Week Range
4.14
-27.86%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.68
Today’s open1.65
Day’s range1.65 - 1.65
Volume1,000
Average volume (3 months)8,638
Market cap$8.7M
Data as of 10:35am ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+35.49%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.73

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc+0.24+6.32%
CYANCyanotech Corp+0.08+1.84%
IBIOIbio Inc+0.00+1.25%
ISRIsoRay Inc+0.03+5.68%
Data as of 10:42am ET, 04/25/2018

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$2.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts